The Bioprinted ‘Play Dough’ capable of Cell and Protein Transfer
News Jul 07, 2015
The scientists demonstrated that the bioprinted material, in the form of a micro-particle paste capable of being injected via a syringe, could sustain stresses and strains similar to cancellous bone – the ‘spongy’ bone tissue typically found at the end of long bones.
This work suggests that bioprinting at ambient temperatures is a viable route to the production of materials for bone repair which would allow the inclusion of cells and proteins capable of accelerating the healing of large fractures.
“Bioprinting is a hot research area in tissue engineering,” explains Dr Jing Yang, of the University of Nottingham. “However it usually requires a printing environment that isn’t compatible with living cells – and those materials that are compatible with living cells usually don’t have sufficient mechanical properties for certain applications.”
“Initially we’re targeting the clinical application of this material as injectable bone defect filler,” continues Dr Yang, “but we’ve postulated that its properties would make it highly suitable for use as a scaffold to reconstruct larger shapes, which could help with more complicated reconstructions – such as nasal reconstruction.”
Typically, bioprinting techniques involve high temperature processes, or the application of ultraviolet light or organic solvents, all of which prevent the incorporation of cells and therapeutic biomolecules during the fabrication process.
This technique involved blending poly(L-lactic-co-glycolic acid) and polyethylene glycol with carrier fluids at room temperature to form a micro-particulate extrudable paste that can be formed to desired shapes. These pastes were incubated at 37 °C to form porous solid constructs. The next steps of the process will be to apply this process in a clinical application.
3D Printer Developed That Can Create Complex Biological TissuesNews
A UCLA bioengineer has developed a technique that uses a specially adapted 3D printer to build therapeutic biomaterials from multiple materials. The advance could be a step toward on-demand printing of complex artificial tissues for use in transplants and other surgeries.READ MORE
Horizon Discovery Appoints Terry Pizzie as Chief Executive OfficerNews
Horizon Discovery Group plc is pleased to announce the appointment of Terry Pizzie as Chief Executive Officer and Board Director with immediate effect.READ MORE
Porvair Sciences Makes Strategic Appointment for US Microplate BusinessNews
Porvair Sciences and J.G. Finneran Associates are pleased to announce the appointment of Bob Brino as OEM Business Development Manager for their microplate and sample prep product lines.READ MORE
Comments | 0 ADD COMMENT
Epigenetics in the nervous system: development and disease
Oct 01 - Oct 03, 2018